Fresenius Raises 2026 Outlook After Q3 Beat
Healthcare group Fresenius lifted its full year expectations after reporting higher than anticipated third quarter results. Strong performances at the Kabi and Helios divisions supported earnings. The company now expects improved profit margins.
Xurve View
Perspectivas:
Xurve View
Fresenius SE & Co KGaA raised its 2026 constant-currency core EPS growth outlook to the upper end of 10%-15% on Wednesday morning. It marks the healthcare group's second guidance upgrade this year following stronger-than-anticipated third-quarter earnings. The revision highlights CEO Michael Sen's turnaround strategy aimed at expanding profitability and cutting debt.
